Who
Arundathy N. Pandite
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Shattuck Labs; Director, Codiak BioSciences.
In numbers
- Trades disclosed
- 30
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $817K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 22 Dec 2020
- Last trade
- 30 Jun 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 2 Jul 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Sold | $210K30,000 at $7.01 | filing |
| 30 Jun 2026filed 2 Jul 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Sold | $210K30,000 at $7.01 | filing |
| 12 May 2026filed 14 May 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Sold | $198K30,000 at $6.61 | filing |
| 12 May 2026filed 14 May 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Sold | $198K30,000 at $6.61 | filing |
| 25 Jan 2026filed 27 Jan 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $13K3,195 at $4.15 | filing |
| 25 Jan 2026filed 27 Jan 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $13K3,195 at $4.15 | filing |
| 10 Jan 2026filed 13 Jan 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $33K6,851 at $4.75 | filing |
| 10 Jan 2026filed 13 Jan 2026 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —487,800 at $0.00 | filing |
| 10 Jan 2026filed 13 Jan 2026 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —487,800 at $0.00 | filing |
| 10 Jan 2026filed 13 Jan 2026 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $33K6,851 at $4.75 | filing |
| 28 Jan 2025filed 28 Jan 2025 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —206,200 at $0.00 | filing |
| 25 Jan 2025filed 28 Jan 2025 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $3,7253,211 at $1.16 | filing |
| 10 Jan 2025filed 13 Jan 2025 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $8,1926,884 at $1.19 | filing |
| 30 Jan 2024filed 31 Jan 2024 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $29K2,920 at $9.99 | filing |
| 10 Jan 2024filed 16 Jan 2024 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —92,950 at $0.00 | filing |
| 10 Jan 2024filed 16 Jan 2024 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code A | —46,475 at $0.00 | filing |
| 10 Jan 2024filed 16 Jan 2024 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $30K2,987 at $10.09 | filing |
| 25 Jan 2023filed 27 Jan 2023 | STTK Shattuck Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —69,750 at $0.00 | filing |
| 25 Jan 2023filed 27 Jan 2023 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code A | —37,875 at $0.00 | filing |
| 10 Jan 2023filed 12 Jan 2023 | STTK Shattuck LabsBiotechnology | SEC FORM 4 Code F | $9,0512,987 at $3.03 | filing |
News
Shattuck Labs (STTK) – Research Analysts' Recent Ratings ChangesSTTK · dailypolitical.com · 22 Oct 2026Pinnacle Associates Ltd. Purchases 228,337 Shares of Shattuck Labs, Inc. $STTKSTTK · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Arundathy N. Pandite; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.